Blair William & Co. IL Purchases 14,967 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Blair William & Co. IL increased its stake in Prestige Consumer Healthcare by 16.4% during the first quarter, acquiring an additional 14,967 shares to own 106,114 shares total, valued at approximately $9.12 million.
• Prestige Consumer Healthcare reported an EPS of $1.32 for the last quarter, surpassing market expectations, with revenues totaling $296.52 million, reflecting a 7.0% increase year-over-year.
• Analyst ratings for Prestige Consumer Healthcare have been generally positive, with a consensus rating of "Moderate Buy" and an average target price of $93.33.

Blair William & Co. IL lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 16.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 106,114 shares of the company's stock after purchasing an additional 14,967 shares during the period. Blair William & Co. IL owned 0.21% of Prestige Consumer Healthcare worth $9,123,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. CIBC Private Wealth Group LLC grew its stake in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after buying an additional 152 shares during the last quarter. Opal Wealth Advisors LLC bought a new position in shares of Prestige Consumer Healthcare during the first quarter worth approximately $38,000. Headlands Technologies LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $40,000. McIlrath & Eck LLC boosted its stake in Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares during the period. Finally, Johnson Financial Group Inc. acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at $93,000. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of recent research reports. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH stock traded up $1.05 during mid-day trading on Wednesday, reaching $75.09. 451,267 shares of the company traded hands, compared to its average volume of 424,802. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The company has a market capitalization of $3.71 billion, a P/E ratio of 17.50, a P/E/G ratio of 2.22 and a beta of 0.43. The company has a fifty day moving average price of $80.00 and a 200-day moving average price of $82.19.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The company's revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.02 EPS. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.